What would you pay for this pipeline? All except oxytocin would be 505(b)(2) abbreviated approval processes.
Buprenorphine for Opioid Dependence: Approved Buprenorphine for Chronic Pain: Ready for Phase 3 Ropinirole for Parkinson’s: Phase I T3 for hypothyroidism: Ready for IND Piperaquine for Malaria: Pre-Clinical Liraglutide for Type 2 Diabetes: Pre-Clinical Oxytocin for Autism: Pre-Clinical
Waaaay beyond my comprehension----But----If I could, I would pick the brains of Merck CEO Frazier, Smith Glaxo Kline CEO Emma Walmsley & TEVA interim CEO Peterburg. They just might be "drooling" over this situation as we speak----or----too bizzy with their own debacles to even take notice. Someone needs to put this under their noses.